Humana Inc. $HUM Holdings Boosted by UniSuper Management Pty Ltd

UniSuper Management Pty Ltd raised its position in shares of Humana Inc. (NYSE:HUM) by 19.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,575 shares of the insurance provider’s stock after purchasing an additional 2,398 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Humana were worth $3,792,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of HUM. Revolve Wealth Partners LLC purchased a new stake in Humana in the 4th quarter worth about $202,000. Woodline Partners LP increased its holdings in shares of Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after purchasing an additional 8,372 shares during the period. Sivia Capital Partners LLC boosted its holdings in shares of Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after purchasing an additional 452 shares during the period. Patton Fund Management Inc. acquired a new stake in shares of Humana during the second quarter worth approximately $203,000. Finally, State of Alaska Department of Revenue grew its position in Humana by 20.8% during the second quarter. State of Alaska Department of Revenue now owns 17,072 shares of the insurance provider’s stock valued at $4,173,000 after purchasing an additional 2,935 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on HUM. Barclays reissued an “underperformer” rating on shares of Humana in a research note on Monday, January 5th. Morgan Stanley reiterated an “underperform” rating on shares of Humana in a report on Thursday, December 18th. KeyCorp restated a “sector weight” rating on shares of Humana in a research note on Friday, December 12th. Wells Fargo & Company lowered Humana from an “overweight” rating to a “cautious” rating in a report on Wednesday, January 7th. Finally, Jefferies Financial Group raised Humana from a “hold” rating to a “buy” rating and boosted their price target for the company from $253.00 to $313.00 in a research note on Friday, December 5th. Eight research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $293.37.

Humana Price Performance

Shares of NYSE:HUM opened at $263.23 on Tuesday. The stock has a market capitalization of $31.66 billion, a P/E ratio of 24.67, a P/E/G ratio of 2.19 and a beta of 0.45. The business has a 50-day moving average of $258.84 and a two-hundred day moving average of $265.08. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $315.35. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. The business had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.The firm’s revenue was up 11.1% compared to the same quarter last year. During the same period last year, the business earned $4.16 EPS. On average, equities research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.